Investor Relations
Best-in-RAS
Corporate Profile
BBOT is a clinical-stage biopharmaceutical company with the mission of transforming the lives of patients with cancers driven by RAS and PI3Kα, the two most frequently mutated oncogenes. Our strategy is to accelerate scientific and medical breakthroughs with the goal of delivering well-tolerated, safe medicines with greater efficacy to people facing the deadliest cancers.